Dechert advises on medtech acquisition

The global law firm has advised a US-based medtech company on its acquisition of testing facilities in Ge…

The global law firm has advised a US-based medtech company on its acquisition of testing facilities in Georgia and Minnesota.

Global law firm Dechert announced last week (17 January) its role in advising medtech testing, clinical and regulatory consulting firm NAMSA on its definitive agreement to acquire the US medical device testing units of WuXi AppTec.

The team at Dechert was headed by corporate partners Michael Darby and Alain Decombe, and further comprised tax partner Kevin Zaragoza, employee benefits partner Kevin Kay, and national security partner Jeremy Zucker.

NAMSA will acquire WuXi AppTec’s testing centres in Georgia and Minnesota as part of its efforts to expand its clinical research and testing solutions for clients. The stringent regulatory and clinical evidence requirements facing the medtech industry often causes delays in development and increases costs and barriers to market entry. NAMSA seeks to bolster its outsourcing and in-house services in order to help clients mitigate risk, improve stakeholder value and decrease market entry barriers.

The transaction marks the ninth acquisition undertaken by NAMSA since it became an ARCHIMED company in 2020. ARCHIMED is a global investment firm focusing on the healthcare sector.

NAMSA CEO André-Michel Ballester said: “We are extremely pleased to announce our agreement with WuXi AppTec, as it enables us to expand our portfolio of clinical research and testing solutions for clients. NAMSA and WuXi AppTec’s medical device testing operations have different areas of expertise but serve the same client base and will enhance the client experience by combining capabilities. Together, we look forward to accelerating MedTech innovation and helping Sponsors deliver life-saving medical technology throughout the world.”

Dechert has advised on various transactions in the past month, including Mount Logan Capital’s merger with 180 Degree Capital and Court Square Capital Partners’ investment in Thrive.

_{Images are for reference only.Images and contents gathered automatic from google or 3rd party sources.All rights on the images and contents are with their legal original owners.}